Lung cancer, Pleural Disorders Flashcards
1
Q
Lung cancer
- risk factors
- prevention
A
- main one: cigarette smoking
- occupational factors: radon, asbestos, arsenic, chromium, vinyl chloride…
- no smoking
- screening as early as possible –> low dose spiral CT
- problem: symptoms only begin when disease has already progressed a lot
2
Q
Lung cancer
-2 major types
A
- Non-small cell (87%)
- most cases tumor is only found when the disease has already progressed –> prognosis is bad - Small cell
- surgery is not possible
3
Q
Lung cancer
- symptoms
- metastasis
A
- non-specific
- persistent cough, sputum with some blood, chest pain, voice change, recurrent pneumonia or bronchitis
-CNS, pleura, liver, bone, adrenals
4
Q
Lung cancer
-diagnostics
A
- bronchoscopy, transthoracic CT guided needle biopsy, radical probe EBUS
- PET-CT –> if radical treatment is considered
- Diagnosis should only be made after biopsy and pathologist’s confirmation
- MRI of the head for SCLC, if symptoms, for stage 3 NSCLC
- mediastinal staging
5
Q
Lung cancer
-treatment options
A
- surgery
- never do surgery if the staging of lymph nodes came back positive
- radiation
- systemic therapy: chemo, immunotherapy…
- much more effective to operate a person that has no symptoms –> prognosis is much better
6
Q
Lung cancer
-treatment strategies for NSCLC
A
- resectable –> stage I, II, and some III
- unresectable –> stage III
- surgery with or without chemo
7
Q
Lung cancer
-Anaplastic lymphoma kinase
A
- receptor tyrosine kinase that is normally not expressed in the lung
- found in 4% of patients with NSCLC
- more frequently in young and non-smoking patients
8
Q
Lung cancer
-EGFT mutations
A
- more commonly in severe smokers, adenocarcinomas, women, Asians
- fond in 10-15% of lung cancer patients
9
Q
SCLC vs. NSCLC
- association with smoking:
- growth kinetics:
- early metastasis:
- sensitivity to DNA damaging chemo:
- sensitivity to radiotherapy:
- advances in therapy:
A
SCLC
- association with smoking: universal
- growth kinetics: rapid
- early metastasis: universal
- sensitivity to DNA damaging chemo: high
- sensitivity to radiotherapy: high
- advances in therapy: few advances
NSCLC
- association with smoking: highly variable
- growth kinetics: variable
- early metastasis: variable
- sensitivity to DNA damaging chemo: variable
- sensitivity to radiotherapy: variable
- advances in therapy: dramatic advances
10
Q
Pleural disorders
-pathogenesis (5)
A
- altered pleural membrane permeability
- decrease intravascular oncotic pressure
- increase capillary hydrostatic pressure
- lymphatic obstruction
- abnormal sites of entry
11
Q
Pleural disorders
- symptoms
- physical exam
A
-cough, dyspnea, pain
- dullness to percussion, decreased breath sounds, asymmetric chest expansion
- decreased or absent vocal resonance and tactile vocal fremitus
12
Q
Pleural disorders
-radiology (4)
A
- x-ray: PA and lateral decub –> blunting of either costophrenic angle
- ultrasound
- CT: super sensitive, helps to see underlying lung, distinguish between lung abscess and empyema
- MRI: pleural effusion, pleural tumor, chest wall invasion
13
Q
Pleural disorders
-3 main questions that should be made
A
- should thoracocentesis be performed?
- if yes, is the fluid transudate or exudate?
- if exudate, what’s the etiology?
14
Q
Pleural disorders
- Thoracocentesis
1. indications (2)
2. contraindications (4)
A
- diagnostics (>10mm depth on lateral decubitus), therapeutically for symptomatic relief
- absolute –> none, relative –> small volume of fluid, patient on anti-coagulant, mechanical vent., active skin infection at the point of entry
15
Q
Pleural disorders
-the color of the fluid and suggested diagnosis
A
- pale yellow - transudate, some exudate
- red - bloody - malignancy or embolism or trauma
- turbid - infected effusion
- pus - empyema
- white - chylothorax or cholesterol infusion